Mark Hill
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- T-cell and B-cell Immunology 2
- Immunotherapy and Immune Responses 2
- Immunodeficiency and Autoimmune Disorders 1
- Immune Cell Function and Interaction 1
-
- Monoclonal and Polyclonal Antibodies Research 2
- Radiopharmaceutical Chemistry and Applications 1
- Co-authors
- Surinder K. Batra (1 shared paper)Peter A. Humphrey (1 shared paper)Shekar N. Kurpad (1 shared paper)Charles N. Pegram (1 shared paper)Carol J. Wikstrand (1 shared paper)David K. Moscatello (1 shared paper)Roger E. McLendon (1 shared paper)Craig J. Reist (1 shared paper)
- Journals
- The Journal of Experimental Medicine (1 paper)The Journal of Immunology (1 paper)European Journal of Immunology (1 paper)PubMed (1 paper)
- Partner nations
- United KingdomUnited StatesSwitzerland
In The Last Decade
Mark Hill
4 papers receiving 544 citations
Peers
Comparison fields: 5 of 54
- Immunology 235
- Oncology 243
- Genetics 79
- Radiology, Nuclear Medicine and Imaging 158
- Structural Biology 4
Countries citing papers authored by Mark Hill
This map shows the geographic impact of Mark Hill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Hill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Hill more than expected).
Fields of papers citing papers by Mark Hill
This network shows the impact of papers produced by Mark Hill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Hill. The network helps show where Mark Hill may publish in the future.
Co-authors
The 22 scholars most cited alongside Mark Hill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Monoclonal antibodies against EGFRvIII are tumor specific and react with breast and lung carcinomas and malignant gliomas. | 1995 | 385 |
| 2 | 1992 | 123 | |
| 3 | 1999 | 32 | |
| 4 | 1989 | 14 |
About Mark Hill
Mark Hill is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging, Oncology, Epidemiology and Genetics, having authored 4 papers that have together received 554 indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Immunotherapy and Immune Responses (2 papers), Influenza Virus Research Studies (1 paper), Immunodeficiency and Autoimmune Disorders (1 paper), Diabetes and associated disorders (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper) and Immune Cell Function and Interaction (1 paper). The work is most often cited by research in Immunology (235 citations), Oncology (243 citations), Genetics (79 citations), Radiology, Nuclear Medicine and Imaging (158 citations) and Structural Biology (4 citations). Mark Hill has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include Surinder K. Batra, Peter A. Humphrey, Shekar N. Kurpad, Charles N. Pegram, Carol J. Wikstrand, David K. Moscatello, Roger E. McLendon, Craig J. Reist, Laura P. Hale and Robyn E. O’Hehir. Their work appears in journals such as The Journal of Experimental Medicine, The Journal of Immunology, European Journal of Immunology and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.